Palomino Laboratories PALX
OTC PALX
$17.10 +0.10 (+0.59%)
At close: Sep 25, 2026 · 4:00 PM EDT

Palomino Laboratories Inc. (PALX) EBIT (2023 - 2025)

Updated

Palomino Laboratories (PALX) recorded EBIT of -$1.6 million in Q3 2025, compared with -$1,234 a year earlier.

Analysis

Palomino Laboratories Inc. (PALX) EBIT (2023 - 2025) Analysis & Trends

On a TTM basis, Palomino Laboratories' EBIT came in at -$2.1 million as of Sep 30, 2025; for FY2024, it was -$140,080.

  • Across earlier years, EBIT came in at -$83,937 in FY2023.
  • The Q3 2025 figure is the lowest quarterly EBIT in data going back to Q3 2023.
  • Per Business Quant, the preceding three quarters came in at -$337,445 (Q2 2025), -$17,828 (Q1 2025) and -$137,962 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.60 Mn
Jun 30, 2025 -337,445.00
Mar 31, 2025 -17,828.00
Dec 31, 2024 -137,962.00
Sep 30, 2024 -1,234.00
Jun 30, 2024 -31,791.00
Mar 31, 2024 -51,304.00
Dec 31, 2023 -32,574.00
Sep 30, 2023 -42,863.00
API Access

Palomino Laboratories Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=PALX&period=max&api_key=YOUR_API_KEY